IgG heavy-chain subclass restriction of thyrotropin-binding inhibitory immunoglobulins in Graves' disease
- PMID: 1977589
- DOI: 10.1111/j.1365-2362.1990.tb01877.x
IgG heavy-chain subclass restriction of thyrotropin-binding inhibitory immunoglobulins in Graves' disease
Abstract
The IgG subclass composition of antibodies is an important determinant of their function. Thyrotropin receptor antibodies cause the hyperthyroidism of Graves' disease but their subclass distribution has been incompletely investigated. We have therefore purified IgG subclasses from Graves' sera by passage over affinity columns designed to deplete all but a single subclass, and then assayed those pure subclass fractions for their ability to displace radiolabelled thyrotropin from its solubilized receptor as a measure of thyrotropin receptor antibody activity. Sufficient activity was recovered for analysis in nine of 10 Graves' patients, in five of whom activity was almost completely (97-100%) restricted to the IgG1 subclass; in the remaining four patients the response was predominantly IgG1 and IgG4 with marked under-representation of the IgG2 subclass. This contrasts with the unrestricted subclass response, in the same fractions, for autoantibodies against thyroglobulin and microsomes. These results suggest that there may be a primary defect at the B-cell level in Graves' disease.
Similar articles
-
Thyroid-stimulating antibody activity between different immunoglobulin G subclasses.J Clin Invest. 1990 Sep;86(3):723-7. doi: 10.1172/JCI114768. J Clin Invest. 1990. PMID: 2168443 Free PMC article.
-
IgG subclass distribution of thyroid autoantibodies: a 'fingerprint' of an individual's response to thyroglobulin and thyroid microsomal antigen.Clin Endocrinol (Oxf). 1987 Mar;26(3):335-46. doi: 10.1111/j.1365-2265.1987.tb00791.x. Clin Endocrinol (Oxf). 1987. PMID: 3652478
-
Affinity-enrichment of thyrotropin receptor autoantibodies from Graves' patients and normal individuals provides insight into their properties and possible origin from natural antibodies.J Clin Endocrinol Metab. 2004 Sep;89(9):4734-45. doi: 10.1210/jc.2003-032068. J Clin Endocrinol Metab. 2004. PMID: 15356088
-
[The significance of microsomal antibodies, thyroglobulin antibodies, thyrotropin receptor antibodies in the diagnosis of thyroid diseases].Internist (Berl). 1988 Aug;29(8):538-40. Internist (Berl). 1988. PMID: 3053504 Review. German. No abstract available.
-
Thyroid autoantibodies.Endocrinol Metab Clin North Am. 2001 Jun;30(2):315-37, viii. doi: 10.1016/s0889-8529(05)70189-4. Endocrinol Metab Clin North Am. 2001. PMID: 11444165 Review.
Cited by
-
Identification of thyroid stimulating hormone receptor-specific T cells in Graves' disease thyroid using autoantigen-transfected Epstein-Barr virus-transformed B cell lines.J Clin Invest. 1995 Jul;96(1):30-7. doi: 10.1172/JCI118034. J Clin Invest. 1995. PMID: 7615799 Free PMC article.
-
Immunity to the thyroid-stimulating hormone receptor.Springer Semin Immunopathol. 1993;14(3):309-21. doi: 10.1007/BF00195980. Springer Semin Immunopathol. 1993. PMID: 8438211 Review. No abstract available.
-
Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress.BioDrugs. 2025 May;39(3):373-409. doi: 10.1007/s40259-025-00708-2. Epub 2025 Mar 29. BioDrugs. 2025. PMID: 40156757 Free PMC article. Review.
-
Thyroid antibody-negative euthyroid Graves' ophthalmopathy.Endocrinol Diabetes Metab Case Rep. 2016;2016:160008. doi: 10.1530/EDM-16-0008. Epub 2016 Jun 2. Endocrinol Diabetes Metab Case Rep. 2016. PMID: 27284451 Free PMC article.
-
Serum total IgG and IgG4 levels in thyroid eye disease.Int Med Case Rep J. 2016 Oct 20;9:325-328. doi: 10.2147/IMCRJ.S116331. eCollection 2016. Int Med Case Rep J. 2016. PMID: 27799828 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources